Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 10.21
+0.43 (4.40%)
At close: Aug 20, 2026
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 94.55M CNY in the quarter ending March 31, 2026, a decrease of -13.20%. This brings the company's revenue in the last twelve months to 432.19M, down -15.11% year-over-year. In the year 2025, Sinotherapeutics had annual revenue of 446.57M, down -12.71%.
Revenue (ttm)
432.19M
Revenue Growth
-15.11%
P/S Ratio
10.16
Revenue / Employee
1.35M
Employees
319
Market Cap
4.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 446.57M | -65.05M | -12.71% |
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Jianmin Pharmaceutical Group | 3.35B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Qianjiang Yongan Pharmaceutical | 847.91M |
| Teyi Pharmaceutical Group Co.,Ltd | 839.27M |
| Harbin Medisan Pharmaceutical | 813.23M |